Fri, Oct 31, 2014, 2:14 AM EDT - U.S. Markets open in 7 hrs 16 mins

Recent

% | $
Quotes you view appear here for quick access.

Sunesis Pharmaceuticals, Inc. Message Board

  • homebuilder_watcher homebuilder_watcher Jan 15, 2013 8:27 AM Flag

    Stock up on new coverage by Credit Suisse, Buy and $7 target

    Credit Suisse Assumes Coverage on Sunesis Pharmaceuticals (SNSS)
    Posted by Kristian Gore on Jan 15th, 2013 // No Comments

    Credit Suisse assumed coverage on shares of Sunesis Pharmaceuticals (NASDAQ: SNSS) in a research note issued to investors on Tuesday. The firm issued an outperform rating and a $7.00 target price on the stock.

    Separately, analysts at Wells Fargo initiated coverage on shares of Sunesis Pharmaceuticals in a research note to investors on Wednesday, December 19th. They set an outperform rating on the stock.

    Sunesis Pharmaceuticals opened at 4.00 on Tuesday. Sunesis Pharmaceuticals has a 1-year low of $1.23 and a 1-year high of $6.85. The stock’s 50-day moving average is currently $4.32. The company’s market cap is $206.0 million.

    Sunesis Pharmaceuticals last released its earnings data on Thursday, November 8th. The company reported ($0.37) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.11) by $0.26. The company had revenue of $0.26 million for the quarter, compared to the consensus estimate of $4.17 million. During the same quarter in 2012, the company posted ($0.11) earnings per share. The company’s revenue for the quarter was down 74.0% on a year-over-year basis. On average, analysts predict that Sunesis Pharmaceuticals will post $-1.03 earnings per share for the current fiscal year.

    Sunesis Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of hematologic and solid tumor cancers.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
SNSS
1.70+0.01(+0.59%)Oct 30 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.